May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Risk Factors for the Incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS)
Author Affiliations & Notes
  • D.F. Martin
    Emory Eye Center, Atlanta, GA, United States
  • N.M. Bressler
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, United States
  • S.B. Bressler
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, United States
  • E.Y. Chew
    National Eye Institute, National Institutes of Health, Bethesda, MD, United States
  • T.E. Clemons
    Emmes Corporation, Rockville, MD, United States
  • R. Klein
    Dept Ophthalmology, University of Wisconsin, Madison, WI, United States
  • J.M. Seddon
    Massachusetts Eye and Ear Infirmary, Boston, MA, United States
  • AREDS Research Group
    Massachusetts Eye and Ear Infirmary, Boston, MA, United States
  • Footnotes
    Commercial Relationships  D.F. Martin, None; N.M. Bressler, None; S.B. Bressler, None; E.Y. Chew, None; T.E. Clemons, None; R. Klein, None; J.M. Seddon, None.
  • Footnotes
    Support  Supported by contracts from NEI/NIH; additional support from Bausch & Lomb, Inc.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 3077. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D.F. Martin, N.M. Bressler, S.B. Bressler, E.Y. Chew, T.E. Clemons, R. Klein, J.M. Seddon, AREDS Research Group; Risk Factors for the Incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3077.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To describe the association of risk factors with the 6.3-year incidence of neovascular age-related macular degeneration (AMD) and geographic atrophy in AREDS. Methods: Incidence of neovascular AMD and of geographic atrophy was assessed in AREDS from stereoscopic color fundus photographs taken at baseline and at annual visits. Baseline risk factors were considered in 5 groups: demographic, medical history, use of medications and ocular (separating non-retinal from retinal). Staged model-building with repeated-measures logistic regression was used to identify and assess significant baseline risk factors separately for incident neovascular AMD and geographic atrophy, among 2,506 participants with 6.3 years average follow-up (maximum 8.1 years) at some risk of developing advanced AMD. Results: In multivariable models, while controlling for age and AREDS treatment group, the following variables were statistically significantly associated with the incidence of neovascular AMD: race (white vs black, OR 6.66, 95% CI: 1.23, 36.2), antacid use (OR 1.72, 95% CI: 1.00, 2.95), and amount smoked (>10 pack years vs #10 pack years, OR 1.48, 95% CI: 1.10, 1.98). Amount smoked (OR 1.93, 95% CI: 1.29, 2.88), greater body mass index (obese vs normal, OR 1.60, 95% CI: 1.02, 2.52), education (college grad. vs. high school grad. or less, OR 0.57, 95% CI: 0.34, 0.94), hormone replacement therapy use in women only (OR 0.52, 95% CI: 0.30, 0.90), and iris color (dark vs light, OR 0.37, 95% CI: 0.14, 0.99) were statistically significantly associated with the incidence of central geographic atrophy. When drusen area and pigmentary abnormalities were added to each model, few associations remained statistically significant. Increasing levels of drusen area were significantly associated with increasing risk of neovascular AMD (OR 1.3 to 7.2) and of central geographic atrophy (OR 3.7 to 14.0). Increasing levels of pigment abnormalities also showed increased risk of neovascular AMD (OR 2) and of central geographic atrophy (OR 3 to 21). Conclusions: These data identify several environmental and systemic exposures that are associated with the development of incident advanced AMD. Drusen area and pigment abnormalities are the most strongly associated risk factors.

Keywords: age-related macular degeneration • clinical (human) or epidemiologic studies: pre • clinical (human) or epidemiologic studies: ris 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×